On the contrary, Xist inhibits cell proliferation in triple-negative breast cancer, a subtype of breast cancer, and deficiency of salivary Xist expression promotes risk of oral squamous cell carcinoma [61]. Here, XIST is linked to oral cavity squamous cell carcinoma.